TY - JOUR AU - Bray, F. AU - McCarron, P. AU - Parkin, D. M. PY - 2004 DA - 2004// TI - The changing global patterns of female breast cancer incidence and mortality JO - Breast Cancer Res VL - 6 UR - https://doi.org/10.1186/bcr932 DO - 10.1186/bcr932 ID - Bray2004 ER - TY - JOUR AU - Holdaway, I. M. AU - Bowditch, J. V. PY - 1983 DA - 1983// TI - Variation in receptor status between primary and metastatic breast cancer JO - Cancer VL - 52 UR - https://doi.org/3.0.CO;2-O DO - 3.0.CO;2-O ID - Holdaway1983 ER - TY - JOUR AU - Hull, D. F. AU - Clark, G. M. AU - Osborne, C. K. AU - Chamness, G. C. AU - Knight, W. A. AU - McGuire, W. L. PY - 1983 DA - 1983// TI - Multiple estrogen receptor assays in human breast cancer JO - Cancer Res VL - 43 ID - Hull1983 ER - TY - JOUR AU - Brunn Rasmussen, B. AU - Kamby, C. PY - 1989 DA - 1989// TI - Immunohistochemical detection of estrogen receptors in paraffin sections from primary and metastatic breast cancer JO - Pathol Res Pract VL - 185 UR - https://doi.org/10.1016/S0344-0338(89)80286-9 DO - 10.1016/S0344-0338(89)80286-9 ID - Brunn Rasmussen1989 ER - TY - JOUR AU - Li, B. D. AU - Byskosh, A. AU - Molteni, A. AU - Duda, R. B. PY - 1994 DA - 1994// TI - Estrogen and progesterone receptor concordance between primary and recurrent breast cancer JO - J Surg Oncol VL - 57 UR - https://doi.org/10.1002/jso.2930570202 DO - 10.1002/jso.2930570202 ID - Li1994 ER - TY - JOUR AU - Kuukasjärvi, T. AU - Kononen, J. AU - Helin, H. AU - Holli, K. AU - Isola, J. PY - 1996 DA - 1996// TI - Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy JO - J Clin Oncol VL - 14 ID - Kuukasjärvi1996 ER - TY - JOUR AU - Branković-Magić, M. AU - Janković, R. AU - Nesković-Konstantinović, Z. AU - Nikolić-Vukosavljević, D. PY - 2002 DA - 2002// TI - Progesterone receptor status of breast cancer metastases JO - J Cancer Res Clin Oncol VL - 128 UR - https://doi.org/10.1007/s00432-001-0299-9 DO - 10.1007/s00432-001-0299-9 ID - Branković-Magić2002 ER - TY - JOUR AU - Lower, E. E. AU - Glass, E. L. AU - Bradley, D. A. AU - Blau, R. AU - Heffelfinger, S. PY - 2005 DA - 2005// TI - Impact of metastatic estrogen receptor and progesterone receptor status on survival JO - Breast Cancer Res Treat VL - 90 UR - https://doi.org/10.1007/s10549-004-2756-z DO - 10.1007/s10549-004-2756-z ID - Lower2005 ER - TY - JOUR AU - Amir, E. AU - Ooi, W. S. AU - Simmons, C. AU - Kahn, H. AU - Christakis, M. AU - Popovic, S. AU - Kalina, M. AU - Chesney, A. AU - Singh, G. AU - Clemons, M. PY - 2008 DA - 2008// TI - Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies JO - Clin Oncol (R Coll Radiol) VL - 20 UR - https://doi.org/10.1016/j.clon.2008.08.005 DO - 10.1016/j.clon.2008.08.005 ID - Amir2008 ER - TY - JOUR AU - Broom, R. J. AU - Tang, P. A. AU - Simmons, C. AU - Bordeleau, L. AU - Mulligan, A. M. AU - O'Malley, F. P. AU - Miller, N. AU - Andrulis, I. L. AU - Brenner, D. M. AU - Clemons, M. J. PY - 2009 DA - 2009// TI - Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer JO - Anticancer Res VL - 29 ID - Broom2009 ER - TY - JOUR AU - Liedtke, C. AU - Broglio, K. AU - Moulder, S. AU - Hsu, L. AU - Kau, S. W. AU - Symmans, W. F. AU - Albarracin, C. AU - Meric-Bernstam, F. AU - Woodward, W. AU - Theriault, R. L. AU - Kiesel, L. AU - Hortobagyi, G. N. AU - Pusztai, L. AU - Gonzalez-Angulo, A. M. PY - 2009 DA - 2009// TI - Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdp263 DO - 10.1093/annonc/mdp263 ID - Liedtke2009 ER - TY - JOUR AU - Simmons, C. AU - Miller, N. AU - Geddie, W. AU - Gianfelice, D. AU - Oldfield, M. AU - Dranitsaris, G. AU - Clemons, M. J. PY - 2009 DA - 2009// TI - Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases? JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdp028 DO - 10.1093/annonc/mdp028 ID - Simmons2009 ER - TY - JOUR AU - Masood, S. AU - Bui, M. M. PY - 2000 DA - 2000// TI - Assessment of Her-2/neu overexpression in primary breast cancers and their metastatic lesions: an immunohistochemical study JO - Ann Clin Lab Sci VL - 30 ID - Masood2000 ER - TY - JOUR AU - Shimizu, C. AU - Fukutomi, T. AU - Tsuda, H. AU - Akashi-Tanaka, S. AU - Watanabe, T. AU - Nanasawa, T. AU - Sugihara, K. PY - 2000 DA - 2000// TI - c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues JO - J Surg Oncol VL - 73 UR - https://doi.org/3.0.CO;2-2 DO - 3.0.CO;2-2 ID - Shimizu2000 ER - TY - JOUR AU - Tanner, M. AU - Jarvinen, P. AU - Isola, J. PY - 2001 DA - 2001// TI - Amplification of HER-2/neu and topoisomerase IIalpha in primary and metastatic breast cancer JO - Cancer Res VL - 61 ID - Tanner2001 ER - TY - JOUR AU - Gancberg, D. AU - Di Leo, A. AU - Cardoso, F. AU - Rouas, G. AU - Pedrocchi, M. AU - Paesmans, M. AU - Verhest, A. AU - Bernard-Marty, C. AU - Piccart, M. J. AU - Larsimont, D. PY - 2002 DA - 2002// TI - Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites JO - Ann Oncol VL - 13 UR - https://doi.org/10.1093/annonc/mdf252 DO - 10.1093/annonc/mdf252 ID - Gancberg2002 ER - TY - JOUR AU - Edgerton, S. M. AU - Moore, D. AU - Merkel, D. AU - Thor, A. D. PY - 2003 DA - 2003// TI - erbB-2 (HER-2) and breast cancer progression JO - Appl Immunohistochem Mol Morphol VL - 11 UR - https://doi.org/10.1097/00129039-200309000-00003 DO - 10.1097/00129039-200309000-00003 ID - Edgerton2003 ER - TY - JOUR AU - Lear-Kaul, K. C. AU - Yoon, H. R. AU - Kleinschmidt-DeMasters, B. K. AU - McGavran, L. AU - Singh, M. PY - 2003 DA - 2003// TI - Her-2/neu status in breast cancer metastases to the central nervous system JO - Arch Pathol Lab Med VL - 127 ID - Lear-Kaul2003 ER - TY - JOUR AU - Gong, Y. AU - Booser, D. J. AU - Sneige, N. PY - 2005 DA - 2005// TI - Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma JO - Cancer VL - 103 UR - https://doi.org/10.1002/cncr.20987 DO - 10.1002/cncr.20987 ID - Gong2005 ER - TY - JOUR AU - Zidan, J. AU - Dashkovsky, I. AU - Stayerman, C. AU - Basher, W. AU - Cozacov, C. AU - Hadary, A. PY - 2005 DA - 2005// TI - Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease JO - Br J Cancer VL - 93 UR - https://doi.org/10.1038/sj.bjc.6602738 DO - 10.1038/sj.bjc.6602738 ID - Zidan2005 ER - TY - JOUR AU - Tapia, C. AU - Savic, S. AU - Wagner, U. AU - Schönegg, R. AU - Novotny, H. AU - Grilli, B. AU - Herzog, M. AU - Barascud, A. D. AU - Zlobec, I. AU - Cathomas, G. AU - Terracciano, L. AU - Feichter, G. AU - Bubendorf, L. PY - 2007 DA - 2007// TI - HER2 gene status in primary breast cancers and matched distant metastases JO - Breast Cancer Res VL - 9 UR - https://doi.org/10.1186/bcr1676 DO - 10.1186/bcr1676 ID - Tapia2007 ER - TY - JOUR AU - Santinelli, A. AU - Pisa, E. AU - Stramazzotti, D. AU - Fabris, G. PY - 2008 DA - 2008// TI - HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy JO - Int J Cancer VL - 122 UR - https://doi.org/10.1002/ijc.23051 DO - 10.1002/ijc.23051 ID - Santinelli2008 ER - TY - JOUR AU - Lower, E. E. AU - Glass, E. AU - Blau, R. AU - Harman, S. PY - 2009 DA - 2009// TI - HER-2/neu expression in primary and metastatic breast cancer JO - Breast Cancer Res Treat VL - 113 UR - https://doi.org/10.1007/s10549-008-9931-6 DO - 10.1007/s10549-008-9931-6 ID - Lower2009 ER - TY - JOUR AU - Munnink, T. H. O. AU - Nagengast, W. B. AU - Brouwers, A. H. AU - Schröder, C. P. AU - Hospers, G. A. AU - De Hooge, M. N. L. AU - van der Wall, E. AU - van Diest, P. J. AU - de Vries, E. G. E. PY - 2009 DA - 2009// TI - Molecular imaging of breast cancer JO - The Breast VL - 18 UR - https://doi.org/10.1016/S0960-9776(09)70276-0 DO - 10.1016/S0960-9776(09)70276-0 ID - Munnink2009 ER - TY - JOUR AU - Perik, P. J. AU - Lub-De Hooge, M. N. AU - Gietema, J. A. AU - van der Graaf, W. T. AU - de Korte, M. A. AU - Jonkman, S. AU - Kosterink, J. G. AU - van Veldhuisen, D. J. AU - Sleijfer, D. T. AU - Jager, P. L. AU - de Vries, E. G. PY - 2006 DA - 2006// TI - Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.03.8448 DO - 10.1200/JCO.2005.03.8448 ID - Perik2006 ER - TY - JOUR AU - Hospers, G. A. AU - Helmond, F. A. AU - de Vries, E. G. AU - Dierckx, R. A. AU - de Vries, E. F. PY - 2008 DA - 2008// TI - PET imaging of steroid receptor expression in breast and prostate cancer JO - Curr Pharm Des VL - 14 UR - https://doi.org/10.2174/138161208786404362 DO - 10.2174/138161208786404362 ID - Hospers2008 ER - TY - STD TI - National Comprehensive Cancer Network: Practice Guidelines in Oncology - v.1.2010. ID - ref27 ER - TY - STD TI - Breast Cancer Treatment (PDQ). [http://www.cancer.gov/cancertopics/pdq/treatment/breast/patient/] UR - http://www.cancer.gov/cancertopics/pdq/treatment/breast/patient/ ID - ref28 ER - TY - JOUR AU - van Diest, P. J. PY - 2002 DA - 2002// TI - No consent should be needed for using leftover body material for scientific purposes. For JO - BMJ VL - 325 UR - https://doi.org/10.1136/bmj.325.7365.648 DO - 10.1136/bmj.325.7365.648 ID - van Diest2002 ER - TY - JOUR AU - van Diest, P. J. AU - Baak, J. P. AU - Matze-Cok, P. AU - Wisse-Brekelmans, E. C. AU - van Galen, C. M. AU - Kurver, P. H. AU - Bellot, S. M. AU - Fijnheer, J. AU - van Gorp, L. H. AU - Kwee, W. S. PY - 1992 DA - 1992// TI - Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project JO - Hum Pathol VL - 23 UR - https://doi.org/10.1016/0046-8177(92)90313-R DO - 10.1016/0046-8177(92)90313-R ID - van Diest1992 ER - TY - JOUR AU - Powell, R. D. AU - Pettay, J. D. AU - Powell, W. C. AU - Roche, P. C. AU - Grogan, T. M. AU - Hainfeld, J. F. AU - Tubbs, R. R. PY - 2007 DA - 2007// TI - Metallographic in situ hybridization JO - Hum Pathol VL - 38 UR - https://doi.org/10.1016/j.humpath.2007.05.004 DO - 10.1016/j.humpath.2007.05.004 ID - Powell2007 ER - TY - STD TI - Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, et al: American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 28: 2784-2795. ID - ref32 ER - TY - JOUR AU - Slamon, D. J. AU - Godolphin, W. AU - Jones, L. A. AU - Holt, J. A. AU - Wong, S. G. AU - Keith, D. E. AU - Levin, W. J. AU - Stuart, S. G. AU - Udove, J. AU - Ullrich, A. PY - 1989 DA - 1989// TI - Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer JO - Science VL - 244 UR - https://doi.org/10.1126/science.2470152 DO - 10.1126/science.2470152 ID - Slamon1989 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. AU - Schwartz, J. N. AU - Hagerty, K. L. AU - Allred, D. C. AU - Cote, R. J. AU - Dowsett, M. AU - Fitzgibbons, P. L. AU - Hanna, W. M. AU - Langer, A. AU - McShane, L. M. AU - Paik, S. AU - Pegram, M. D. AU - Perez, E. A. AU - Press, M. F. AU - Rhodes, A. AU - Sturgeon, C. AU - Taube, S. E. AU - Tubbs, R. AU - Vance, G. H. AU - van de Vijver, M. AU - Wheeler, T. M. AU - Hayes, D. F. PY - 2007 DA - 2007// TI - American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.2775 DO - 10.1200/JCO.2006.09.2775 ID - Wolff2007 ER - TY - JOUR AU - Cui, X. AU - Schiff, R. AU - Arpino, G. AU - Osborne, C. K. AU - Lee, A. V. PY - 2005 DA - 2005// TI - Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.09.004 DO - 10.1200/JCO.2005.09.004 ID - Cui2005 ER - TY - JOUR AU - Kurbel, S. PY - 2005 DA - 2005// TI - Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers JO - Med Hypotheses VL - 64 UR - https://doi.org/10.1016/j.mehy.2004.09.026 DO - 10.1016/j.mehy.2004.09.026 ID - Kurbel2005 ER - TY - JOUR AU - Kerbel, R. S. PY - 1990 DA - 1990// TI - Growth dominance of the metastatic cancer cell: cellular and molecular aspects JO - Adv Cancer Res VL - 55 UR - https://doi.org/10.1016/S0065-230X(08)60469-8 DO - 10.1016/S0065-230X(08)60469-8 ID - Kerbel1990 ER - TY - JOUR AU - Kuukasjarvi, T. AU - Karhu, R. AU - Tanner, M. AU - Kahkonen, M. AU - Schaffer, A. AU - Nupponen, N. AU - Pennanen, S. AU - Kallioniemi, A. AU - Kallioniemi, O. P. AU - Isola, J. PY - 1997 DA - 1997// TI - Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer JO - Cancer Res VL - 57 ID - Kuukasjarvi1997 ER - TY - STD TI - Wu JM, Halushka MK, Argani P: Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer. Hum Pathol. 41: 914-917. ID - ref39 ER - TY - JOUR AU - Wu, J. M. AU - Fackler, M. J. AU - Halushka, M. K. AU - Molavi, D. W. AU - Taylor, M. E. AU - Teo, W. W. AU - Griffin, C. AU - Fetting, J. AU - Davidson, N. E. AU - De Marzo, A. M. AU - Hicks, J. L. AU - Chitale, D. AU - Ladanyi, M. AU - Sukumar, S. AU - Argani, P. PY - 2008 DA - 2008// TI - Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-4082 DO - 10.1158/1078-0432.CCR-07-4082 ID - Wu2008 ER -